AP2005003248A0 - 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV. - Google Patents

4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV.

Info

Publication number
AP2005003248A0
AP2005003248A0 AP2005003248A AP2005003248A AP2005003248A0 AP 2005003248 A0 AP2005003248 A0 AP 2005003248A0 AP 2005003248 A AP2005003248 A AP 2005003248A AP 2005003248 A AP2005003248 A AP 2005003248A AP 2005003248 A0 AP2005003248 A0 AP 2005003248A0
Authority
AP
ARIPO
Prior art keywords
dicyanophenoxy
hiv
treatment
reverse transcriptase
pyrazole derivatives
Prior art date
Application number
AP2005003248A
Other languages
English (en)
Inventor
Charles Eric Mowbray
David Anthony Price
Matthew Duncan Selby
Paul Anthony Stupple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP2005003248A0 publication Critical patent/AP2005003248A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/293—Saturated compounds containing keto groups bound to rings to a three- or four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/327—Saturated compounds containing keto groups bound to rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2005003248A 2002-09-16 2003-09-08 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV. AP2005003248A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0221477.3A GB0221477D0 (en) 2002-09-16 2002-09-16 Chemical compounds
GBGB0223354.2A GB0223354D0 (en) 2002-09-16 2002-10-08 Chemical compounds
PCT/IB2003/003946 WO2004024147A1 (en) 2002-09-16 2003-09-08 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv

Publications (1)

Publication Number Publication Date
AP2005003248A0 true AP2005003248A0 (en) 2005-03-31

Family

ID=31995706

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003248A AP2005003248A0 (en) 2002-09-16 2003-09-08 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV.

Country Status (20)

Country Link
EP (1) EP1542679B1 (no)
JP (1) JP2006504792A (no)
KR (1) KR20050043962A (no)
CN (1) CN1681494A (no)
AP (1) AP2005003248A0 (no)
AU (1) AU2003263422A1 (no)
BR (1) BR0314243A (no)
CA (1) CA2496315A1 (no)
DE (1) DE60311284T2 (no)
EA (1) EA200500287A1 (no)
EC (1) ECSP055673A (no)
GB (2) GB0221477D0 (no)
HR (1) HRP20050222A2 (no)
IS (1) IS7705A (no)
MA (1) MA27435A1 (no)
MX (1) MXPA05002963A (no)
NO (1) NO20051833L (no)
OA (1) OA12920A (no)
PL (1) PL375976A1 (no)
WO (1) WO2004024147A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100322A1 (en) * 2004-04-14 2005-10-27 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303200A (en) * 1963-11-05 1967-02-07 American Home Prod Pyrazole-1-ethanol derivatives
GB0016787D0 (en) * 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
EE05400B1 (et) * 2001-04-10 2011-04-15 Pfizer Inc. Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks

Also Published As

Publication number Publication date
IS7705A (is) 2005-02-21
AU2003263422A1 (en) 2004-04-30
OA12920A (en) 2006-10-13
GB0223354D0 (en) 2002-11-13
JP2006504792A (ja) 2006-02-09
GB0221477D0 (en) 2002-10-23
EP1542679A1 (en) 2005-06-22
CN1681494A (zh) 2005-10-12
NO20051833L (no) 2005-06-14
HRP20050222A2 (en) 2005-10-31
DE60311284D1 (de) 2007-03-08
PL375976A1 (en) 2005-12-12
MXPA05002963A (es) 2005-05-27
EP1542679B1 (en) 2007-01-17
ECSP055673A (es) 2005-07-06
EA200500287A1 (ru) 2005-10-27
WO2004024147A1 (en) 2004-03-25
BR0314243A (pt) 2005-07-26
MA27435A1 (fr) 2005-07-01
CA2496315A1 (en) 2004-03-25
DE60311284T2 (de) 2007-06-21
KR20050043962A (ko) 2005-05-11

Similar Documents

Publication Publication Date Title
MXPA03007349A (es) Derivados de xantina, su preparacion y su empleo como medicamentos.
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
HK1082744A1 (en) Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
AU2003212282A1 (en) Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
WO2003037864A1 (fr) Compose indolique, et utilisation a des fins therapeutiques
WO2004072031A3 (en) Phenylacetamides and their use as glucokinase modulators
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
AU2002234640A1 (en) Xanthine derivative, production and use thereof as a medicament
HK1056715A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
HK1089671A1 (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
AU2003219100A1 (en) Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
AU2003243765A1 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
PT1532141E (pt) Derivados de 2-pirrolidin-2-il-[1,3,4]-oxadiazole e sua utilização como antidepressivos
HK1066547A1 (en) Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics
MXPA05013034A (es) N-alquinil-2-heteroariloxialquilamidas para uso como fungicidas.